|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2001-1-26
|
|
pubmed:abstractText |
Hepatocellular carcinoma (HCC) is a major cause of death in cirrhotic patients. This neoplasm is associated with liver cirrhosis (LC) in more than 90% of cases. Early diagnosis and treatment of HCC are expected to improve survival of patients.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-10655254,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-11156630,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-12171975,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-12235093,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-1352268,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-13598782,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-1651452,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-1698703,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-1778705,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-2113784,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-2170267,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-2408739,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-2416625,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-2456973,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-2461890,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-2482242,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-2990661,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-2998963,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-3032403,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-3437793,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-4541913,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-7053682,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-7515408,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-7524721,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-7535323,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-7650331,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-7684822,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-7686879,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-7875483,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-831755,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-8464435,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-8651169,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-8674404,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-8780534,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-8861994,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-8873514,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-9425947,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-9691106,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11156649-9862851
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0017-5749
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
251-9
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11156649-Adult,
pubmed-meshheading:11156649-Aged,
pubmed-meshheading:11156649-Aged, 80 and over,
pubmed-meshheading:11156649-Carcinoma, Hepatocellular,
pubmed-meshheading:11156649-Case-Control Studies,
pubmed-meshheading:11156649-Cohort Studies,
pubmed-meshheading:11156649-Cost-Benefit Analysis,
pubmed-meshheading:11156649-Female,
pubmed-meshheading:11156649-Follow-Up Studies,
pubmed-meshheading:11156649-Health Care Costs,
pubmed-meshheading:11156649-Humans,
pubmed-meshheading:11156649-Liver,
pubmed-meshheading:11156649-Liver Cirrhosis,
pubmed-meshheading:11156649-Liver Neoplasms,
pubmed-meshheading:11156649-Male,
pubmed-meshheading:11156649-Mass Screening,
pubmed-meshheading:11156649-Middle Aged,
pubmed-meshheading:11156649-Multivariate Analysis,
pubmed-meshheading:11156649-Risk Factors,
pubmed-meshheading:11156649-Survival Rate,
pubmed-meshheading:11156649-alpha-Fetoproteins
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
|
|
pubmed:affiliation |
Dipartimento di Medicina Interna e Gastroenterologia, Università di Bologna, Italia. bolondi@almadns.unibo.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
